news.stocktradersdaily1d
(BIIB) Pivots Trading Plans and Risk Controls
GET MORE AI-GENERATED SIGNALS: February 14, 2025, 03:48 am ET, BY Barry C.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...
Biogen (NASDAQ:BIIB) Given Hold Rating at Needham & Company LLC
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & ...
Zacks.com on MSN2d
Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance
It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...
Biogen outlook disappoints amid pressure on multiple sclerosis franchise
Biogen (NASDAQ:BIIB) stock traded flat as the company reports better than expected Q4 2024 financials, but its 2025 outlook ...
Biogen (BIIB) Gets a Buy from Mizuho Securities
Mizuho Securities analyst Salim Syed maintained a Buy rating on Biogen (BIIB – Research Report) yesterday and set a price target of $207.00.
Yahoo Finance2d
Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Biogen Inc. (BIIB) reported $2.45 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 2.9%. EPS of $3.44 for the same period compares to $2.95 a year ...
Biogen Inc. (BIIB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...
Biogen Analysts Lower Their Forecasts After Q4 Results
The company posted fourth-quarter adjusted EPS of $3.44, up 17%, beating the consensus of $3.35. The company reported sales ...